Profund Advisors LLC Acquires 154 Shares of FMC Co. (NYSE:FMC)

Posted by Defense World Staff on Apr 23rd, 2023

Profund Advisors LLC grew its holdings in FMC Co. (NYSE:FMC – Get Rating) by 4.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,472 shares of the basic materials company’s stock after purchasing an additional 154 shares during the period. Profund Advisors LLC’s holdings in FMC were worth $433,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of FMC. Raymond James Financial Services Advisors Inc. raised its position in shares of FMC by 9.6% in the first quarter. Raymond James Financial Services Advisors Inc. now owns 10,326 shares of the basic materials company’s stock valued at $1,359,000 after purchasing an additional 908 shares during the period. Acadian Asset Management LLC bought a new stake in FMC during the 1st quarter worth approximately $191,000. Cibc World Market Inc. bought a new stake in FMC during the 1st quarter worth approximately $224,000. Prudential PLC bought a new stake in FMC during the 1st quarter worth approximately $383,000. Finally, National Pension Service increased its holdings in FMC by 872,245.0% during the 1st quarter. National Pension Service now owns 174,469 shares of the basic materials company’s stock worth $22,955,000 after acquiring an additional 174,449 shares during the period. Institutional investors own 88.28% of the company’s stock.

FMC Price Performance

Shares of FMC stock opened at $123.22 on Friday. FMC Co. has a 52-week low of $98.24 and a 52-week high of $136.96. The stock has a market capitalization of $15.42 billion, a price-to-earnings ratio of 21.17, a price-to-earnings-growth ratio of 1.55 and a beta of 0.82. The company has a fifty day moving average of $123.27 and a 200-day moving average of $124.28. The company has a debt-to-equity ratio of 0.80, a quick ratio of 1.00 and a current ratio of 1.43.

FMC (NYSE:FMC – Get Rating) last announced its quarterly earnings data on Wednesday, February 8th. The basic materials company reported $2.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.32 by $0.05. The company had revenue of $1.62 billion during the quarter, compared to analysts’ expectations of $1.53 billion. FMC had a net margin of 12.69% and a return on equity of 29.29%. The firm’s revenue was up 14.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.16 EPS. Equities research analysts expect that FMC Co. will post 7.93 EPS for the current year.

FMC Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, April 20th. Shareholders of record on Friday, March 31st were given a dividend of $0.58 per share. The ex-dividend date was Thursday, March 30th. This represents a $2.32 annualized dividend and a yield of 1.88%. FMC’s payout ratio is currently 39.86%.

Insider Buying and Selling at FMC

In other FMC news, CFO Andrew D. Sandifer sold 5,000 shares of the stock in a transaction on Thursday, March 2nd. The shares were sold at an average price of $127.77, for a total transaction of $638,850.00. Following the completion of the sale, the chief financial officer now owns 39,061 shares of the company’s stock, valued at approximately $4,990,823.97. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other FMC news, EVP Ronaldo Pereira sold 1,955 shares of the stock in a transaction on Wednesday, March 1st. The shares were sold at an average price of $129.29, for a total transaction of $252,761.95. Following the completion of the sale, the executive vice president now owns 19,478 shares of the company’s stock, valued at approximately $2,518,310.62. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Andrew D. Sandifer sold 5,000 shares of the company’s stock in a transaction on Thursday, March 2nd. The stock was sold at an average price of $127.77, for a total transaction of $638,850.00. Following the completion of the transaction, the chief financial officer now owns 39,061 shares of the company’s stock, valued at $4,990,823.97. The disclosure for this sale can be found here. Insiders sold 11,376 shares of company stock valued at $1,465,016 in the last quarter. Company insiders own 0.85% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently weighed in on FMC shares. UBS Group upped their target price on shares of FMC from $142.00 to $147.00 and gave the stock a “buy” rating in a report on Wednesday, January 11th. BMO Capital Markets upped their target price on shares of FMC from $140.00 to $145.00 and gave the stock an “outperform” rating in a report on Thursday, February 9th. The Goldman Sachs Group upped their target price on shares of FMC from $155.00 to $159.00 and gave the stock a “buy” rating in a report on Tuesday, February 14th. Wells Fargo & Company increased their price target on shares of FMC from $141.00 to $148.00 and gave the stock an “overweight” rating in a report on Monday, January 9th. Finally, StockNews.com started coverage on shares of FMC in a report on Thursday, March 16th. They issued a “buy” rating on the stock. One investment analyst has rated the stock with a sell rating and thirteen have assigned a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $144.38.

FMC Profile

(Get Rating)

FMC Corp. is an agricultural sciences company, which engages in the provision of solutions to growers and development of pipeline in crop protection, plant health, precision agriculture, and professional pest, and turf management. It offers insect control products under the Rynaxypyr and Cyazypyr brands, herbicides under the Authority, Boral, Centium, Command, and Gamit brands, insecticides under the Talstar and Hero brands, flutriafol-based fungicides, and bionematicides under the Quartzo and Presence brands.